NextCure Inc expected to post a loss of 54 cents a share - Earnings Preview

NextCure

27/02/2024 11:19

* NextCure Inc  NXTC.OQ   NXTC.O  is expected to show no
change in
quarterly revenue when it reports  results on February 29
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for NextCure Inc is for a
loss
of 54 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for NextCure
Inc is
$4.00​, above​ its last closing price of $1.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.66       -0.66      -0.51     Beat    22.4
 Jun. 30 2023  -0.59       -0.59      -0.64     Missed  -8.5
 Mar. 31 2023  -0.62       -0.62      -0.58     Beat    6.5​
 Dec. 31 2022  -0.65       -0.66      -0.62     Beat    5.5
 ​​Sep.        -0.62       -0.63      -0.68     Missed  -8.7
 30 2022                                                
 Jun. 30 2022  -0.72       -0.72      -0.65     Beat    9.7​
 Mar. 31 2022  -0.67       -0.67      -0.74     Missed  -10.7
 Dec. 31 2021  -0.67       -0.67      -0.61     Beat    9.1
 This summary was machine generated February 27 at 11:19 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)